As you know, the role of today’s regulatory affairs professional is changing as the life science industries continue to converge. It is becoming increasingly more difficult to remain solely a “medical device” or “pharma” person as combination products continue to become more mainstream. Individuals who can apply their multi-modality expertise across the life science industries are a real asset to the combination products market. According to RAPS research, the number of regulatory professionals involved in combination products has increased from an estimated 12% in 1999 to nearly 30% in 2006.
Continue reading "Calling all Regulatory Affairs Professionals!" »












